Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane

Description

The purpose of this research study is to determine whether early administration of Dexrazoxane prevents Doxorubicin induced cardiotoxicity.

Conditions

Healthy

Study Overview

Study Details

Study overview

The purpose of this research study is to determine whether early administration of Dexrazoxane prevents Doxorubicin induced cardiotoxicity.

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane in Patients with Breast Cancer

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane

Condition
Healthy
Intervention / Treatment

-

Contacts and Locations

Little Rock

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States, 72205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Women,
  • * Age 18-65,
  • * Not pregnant, Not currently breast feeding
  • * No current illness,
  • * Pregnancy, currently breast feeding
  • * Current illness,
  • * History of cardiac, or renal disease

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Arkansas,

Hui-Ming Chang, MD,MPH, PRINCIPAL_INVESTIGATOR, University of Arkansas

Study Record Dates

2026-10-31